Subcranial magnetic stimulation: a novel method of focal, non-invasive deep brain neuromodulation for the treatment of post-traumatic stress disorder.

2014 ◽  
Vol 7 (2) ◽  
pp. e15-e16
Author(s):  
Jonathan R. Young ◽  
Artem Rozkov ◽  
Zhao Li ◽  
Oliver Young ◽  
Tim Barber ◽  
...  
2019 ◽  
Vol 45 (6) ◽  
pp. 940-946 ◽  
Author(s):  
Nicholas J. Petrosino ◽  
Mascha van ’t Wout-Frank ◽  
Emily Aiken ◽  
Hannah R. Swearingen ◽  
Jennifer Barredo ◽  
...  

AbstractTheta burst transcranial magnetic stimulation (TBS) is a potential new treatment for post-traumatic stress disorder (PTSD). We previously reported active intermittent TBS (iTBS) was associated with superior clinical outcomes for up to 1-month, in a sample of fifty veterans with PTSD, using a crossover design. In that study, participants randomized to the active group received a total of 4-weeks of active iTBS, or 2-weeks if randomized to sham. Results were superior with greater exposure to active iTBS, which raised the question of whether observed effects persisted over the longer-term. This study reviewed naturalistic outcomes up to 1-year from study endpoint, to test the hypothesis that greater exposure to active iTBS would be associated with superior outcomes. The primary outcome measure was clinical relapse, defined as any serious adverse event (e.g., suicide, psychiatric hospitalization, etc.,) or need for retreatment with repetitive transcranial magnetic stimulation (rTMS). Forty-six (92%) of the initial study’s intent-to-treat participants were included. Mean age was 51.0 ± 12.3 years and seven (15.2%) were female. The group originally randomized to active iTBS (4-weeks active iTBS) demonstrated superior outcomes at one year compared to those originally randomized to sham (2-weeks active iTBS); log-rank ChiSq = 5.871, df = 1, p = 0.015; OR = 3.50, 95% CI = 1.04–11.79. Mean days to relapse were 296.0 ± 22.1 in the 4-week group, and 182.0 ± 31.9 in the 2-week group. When used, rTMS retreatment was generally effective. Exploratory neuroimaging revealed default mode network connectivity was predictive of 1-year outcomes (corrected p < 0.05). In summary, greater accumulated exposure to active iTBS demonstrated clinically meaningful improvements in the year following stimulation, and default mode connectivity could be used to predict longer-term outcomes.


The Analyst ◽  
2021 ◽  
Vol 146 (1) ◽  
pp. 170-183
Author(s):  
Ardalan Chaichi ◽  
Syed Mohammad Abid Hasan ◽  
Nishir Mehta ◽  
Fabrizio Donnarumma ◽  
Philip Ebenezer ◽  
...  

We introduce a novel method that provides quantitative lipidomics results from Raman maps in the paraventricular nucleus of the thalamus (PVT) region of post-traumatic stress disorder (PTSD) rat brains.


2019 ◽  
Vol 9 (2) ◽  
pp. 45 ◽  
Author(s):  
Flavia Gouveia ◽  
Darryl Gidyk ◽  
Peter Giacobbe ◽  
Enoch Ng ◽  
Ying Meng ◽  
...  

Post-traumatic stress disorder (PTSD) is an often debilitating disease with a lifetime prevalence rate between 5–8%. In war veterans, these numbers are even higher, reaching approximately 10% to 25%. Although most patients benefit from the use of medications and psychotherapy, approximately 20% to 30% do not have an adequate response to conventional treatments. Neuromodulation strategies have been investigated for various psychiatric disorders with promising results, and may represent an important treatment option for individuals with difficult-to-treat forms of PTSD. We review the relevant neurocircuitry and preclinical stimulation studies in models of fear and anxiety, as well as clinical data on the use of transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), and deep brain stimulation (DBS) for the treatment of PTSD.


Sign in / Sign up

Export Citation Format

Share Document